How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
Thiabendazole CAS 148-79-8 Market
- By Application: Agricultural Fungicide, Post-Harvest Treatment, Seed Treatment, Pharmaceuticals, Animal Health
- By Formulation Type: Wettable Powder (WP), Emulsifiable Concentrate (EC), Suspension Concentrate (SC), Granules (GR), Soluble Powder (SP)
- By End-Use Industry: Crop Protection, Food Processing, Veterinary Medicine, Pharmaceutical Industry
- By Mode of Application: Foliar Spray, Soil Treatment, Seed Coating, Post-Harvest Dipping, Injection
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Agricultural Fungicide leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Thiabendazole CAS 148-79-8 Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
Formulation Type 5
End-Use Industry 4
Mode of Application 5
Companies profiled
BASF SE
Syngenta AG
Bayer Crop Science
ADAMA Agricultural Solutions Ltd.
Nufarm Limited
UPL Limited
Sumitomo Chemical Co. Ltd.
FMC Corporation
Nippon Soda Co. Ltd.
Jiangsu Yangnong Chemical Group Co. Ltd.
Shandong Rainbow Chemical Co. Ltd.
Hebei Veyong Pharmaceutical Co. Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bayer Crop Science
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →ADAMA Agricultural Solutions Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →UPL Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sumitomo Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →FMC Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nippon Soda Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Jiangsu Yangnong Chemical Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Shandong Rainbow Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Hebei Veyong Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Zhejiang Xinan Chemical Industrial Group Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Jiangsu Huifeng Agrochemical & Chemicals Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Lanfeng Bio-Chem Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,821M by 2033 · 6.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Agricultural Fungicide45.6
- Post-Harvest Treatment12.2
- Seed Treatment16.4
- Pharmaceuticals14.8
- Animal Health11.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,144M → $1,883M · 6.4%
Europe$797.2M → $1,276M · 6.1%
Asia Pacific$727.9M → $1,323M · 7.8%
Latin America$450.6M → $746.7M · 6.5%
Middle East and Africa$346.6M → $642.2M · 8.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.642026
6.652027
6.662028
6.682029
6.702030
6.712031
6.712032
6.742033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE22.7
- Syngenta AG13.7
- Bayer Crop Science8.7
- ADAMA Agricultural Solutions Ltd.7.2
- Nufarm Limited8.1
- UPL Limited11.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application33.8%
Formulation Type27.2%
End-Use Industry27.3%
Mode of Application11.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe21.7
- Asia Pacific22.5
- Latin America12.7
- Middle East and Africa10.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 87 | 87 | 90 | 79 | 79 | 78 | 83 |
| Syngenta AG | 88 | 88 | 85 | 90 | 91 | 79 | 87 |
| Bayer Crop Science | 70 | 86 | 87 | 65 | 71 | 81 | 77 |
| ADAMA Agricultural Solutions Ltd. | 62 | 61 | 63 | 67 | 70 | 80 | 67 |
| Nufarm Limited | 66 | 76 | 51 | 67 | 67 | 57 | 64 |
| UPL Limited | 62 | 62 | 52 | 64 | 51 | 51 | 57 |
| Sumitomo Chemical Co. Ltd. | 61 | 60 | 65 | 55 | 57 | 57 | 59 |
| FMC Corporation | 52 | 40 | 46 | 56 | 47 | 57 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Syngenta AG
- Bayer Crop Science
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Syngenta AG | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Bayer Crop Science | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| ADAMA Agricultural Solutions Ltd. | ◐ | ◐ | ◐ | ✓ | − | ✓ |
| Nufarm Limited | − | ✓ | − | − | ◐ | − |
| UPL Limited | ◐ | − | − | − | − | − |
| Sumitomo Chemical Co. Ltd. | − | ◐ | ◐ | − | ◐ | ◐ |
| FMC Corporation | − | − | ◐ | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Syngenta AG87
2BASF SE83
3Bayer Crop Science77
4ADAMA Agricultural Solutions Ltd.67
5Nufarm Limited64
6Sumitomo Chemical Co. Ltd.59
7UPL Limited57
8FMC Corporation50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SESyngenta AG
Challenger2
Strong scale, closing on the leaders.
Bayer Crop ScienceADAMA Agricultural Solutions Ltd.
Contender3
Focused players with pockets of strength.
Nufarm LimitedUPL LimitedSumitomo Chemical Co. Ltd.
Niche1
Specialists in a single segment or region.
FMC Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Thiabendazole CAS 148-79-8 Market — a $234M beachhead inside a $3.52B market.
Beachhead (SOM)$234Mobtainable near-term
Serviceable (SAM)$1.43Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Agricultural Fungicide
Best fit — highest urgency & budget in Application.
Economic buyer76 fit
Post-Harvest Treatment
Strong fit — clear ROI and a fast path to value.
End user65 fit
Seed Treatment
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-Use Industry
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel26%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Thiabendazole CAS 148-79-8 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified21%
Evaluation13%
Closed-won7%
$12.9KCAC
$64KLTV
5.0:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Thiabendazole CAS 148-79-8 Market is a durable-growth opportunity — $2.69B by 2033, compounding at 8.5%.
TAM · 2025$1.40Btoday
TAM · 2033$2.69Bforecast
CAGR8.5%2027–2033
Cumulative$17.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.69BTotal addressable market
SAM$1.08BServiceable available market
SOM$208MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.69BLarge & growingTAM by 2033 at 8.5% CAGR
$1.08BServiceable nowreachable with today’s model
$208MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.10BBear5.6% CAGR
$2.69BBase8.5% CAGR
$3.45BBull11.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Thiabendazole CAS 148-79-8 Market — a $5.71B market by 2033. Plan: grow share from 6.4% to 12.9%.
Market size · 2033$5.71Btotal addressable
Market CAGR7.2%2027–2033
Target share12.9%from 6.4% today
Revenue ambition$736Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.4% | 12.9% | Behind |
| Revenue | $340M | $736M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 33.8% | 40.3% | Ahead |
| Customer retention | 85.5% | 92.8% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation Type capability
A defensible second engine — invest in Formulation Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $89M capacity & capability investment
- Greenlight bolt-on M&A in Formulation Type
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Thiabendazole CAS 148-79-8 Market conversation — a $5.86B market you can size, segment and defend in minutes.
Market size · 2033$5.86Btotal opportunity
Growth5.5%CAGR to 2033
Addressable buyers1,703+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$53K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SESyngenta AGBayer Crop ScienceADAMA Agricultural Solutions Ltd.Nufarm LimitedUPL LimitedSumitomo Chemical Co. Ltd.FMC Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Thiabendazole CAS 148-79-8 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Thiabendazole CAS 148-79-8 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →Chicken Eggs Peeling Machine Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportBrush Hook Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportDiesel Rammer Market
Market size, share, segmentation and regional forecast.
$372M market · 2025 base year
View reportMonopotassium phosphite CAS 13977-65-6 Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportSulfosulfuron CAS 141776-32-1 Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportPaclobutrazol CAS 76738-62-0 Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportDinocap CAS 39300-45-3 Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportTriazophos CAS 24017-47-8 Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportHymexazol CAS 10004-44-1 Market
Market size, share, segmentation and regional forecast.
$423M market · 2025 base year
View reportTerbufos CAS 13071-79-9 Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportAcetamiprid CAS 135410-20-7 Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportAmidosulfuron CAS 120923-37-7 Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.